Does MIDOSTAURIN Cause Bronchopulmonary aspergillosis? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Bronchopulmonary aspergillosis have been filed in association with MIDOSTAURIN (RYDAPT). This represents 0.6% of all adverse event reports for MIDOSTAURIN.
19
Reports of Bronchopulmonary aspergillosis with MIDOSTAURIN
0.6%
of all MIDOSTAURIN reports
5
Deaths
6
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From MIDOSTAURIN?
Of the 19 reports, 5 (26.3%) resulted in death, 6 (31.6%) required hospitalization, and 6 (31.6%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
Yes, Bronchopulmonary aspergillosis is listed as a known adverse reaction in the official FDA drug label for MIDOSTAURIN.
What Other Side Effects Does MIDOSTAURIN Cause?
Death (397)
Nausea (252)
Febrile neutropenia (223)
Diarrhoea (194)
Pyrexia (188)
Acute myeloid leukaemia recurrent (171)
Pancytopenia (152)
Vomiting (152)
Drug ineffective (151)
Thrombocytopenia (140)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which MIDOSTAURIN Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
MIDOSTAURIN vs MIFEPRISTONE
MIDOSTAURIN vs MIGALASTAT
MIDOSTAURIN vs MIGLITOL
MIDOSTAURIN vs MIGLUSTAT
MIDOSTAURIN vs MILNACIPRAN